Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PCNA | P12004 | 14/20 | 1.00 |
| ▸ | THRA | P10827 | 4/20 | 0.75 |
| ▸ | THRB | P10828 | 4/20 | 0.75 |
| ▸ | POLB | P06746 | 2/20 | 0.75 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.75 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.75 |
| ▸ | LIG1 | P18858 | 1/20 | 0.57 |
| ▸ | RXRA | P19793 | 2/20 | 0.55 |
| ▸ | PPARG | P37231 | 2/20 | 0.55 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.55 |
| ▸ | PGR | P06401 | 1/20 | 0.55 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.55 |
| ▸ | HTR1A | P08908 | 1/20 | 0.55 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.55 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.55 |
| ▸ | AR | P10275 | 1/20 | 0.55 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.55 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19663420 | 0.91 | PCNA (0.82) | PCNATHRATHRBPOLBHIF1A | |
| SCHEMBL15500034 | 0.87 | PCNA (0.77) | PCNATHRATHRBPOLBHIF1A | |
| SCHEMBL14485308 | 0.87 | PCNA (0.77) | PCNATHRATHRBPOLBHIF1A | |
| Thyropropic Acid SCHEMBL310201 | 0.86 | PCNA (1.00) | PCNATHRATHRBPOLBHIF1A | |
| SCHEMBL5742613 | 0.85 | PCNA (0.74) | PCNATHRATHRBPOLBHIF1A | |
| SCHEMBL12642750 | 0.85 | PCNA (0.74) | PCNATHRATHRBPOLBHIF1A | |
| SCHEMBL4238467 | 0.84 | THRB (0.73) | PCNATHRATHRBPOLBHIF1A | |
| SCHEMBL16126006 | 0.83 | PCNA (1.00) | PCNATHRATHRBPOLBHIF1A | |
| SCHEMBL14485250 | 0.82 | PCNA (0.70) | PCNATHRATHRBPOLBHIF1A | |
| SCHEMBL12440046 | 0.82 | PCNA (0.69) | PCNATHRATHRBPOLBHIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 767 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250367148-A1 | METHODS FOR TREATING ALLAN-HERNDON-DUDLEY SYNDROME | DEXCEL PHARMA TECHNOLOGIES LTD (IL) | 2025-12-04 | — | — | US | claimed |
| US-12390432-B2 | Methods for treating allan-herndon-dudley syndrome | PriZm, LLC (US) | 2025-08-19 | — | — | US | claimed |
| CN-118834806-B | Bifidobacterium longum subspecies longum and application thereof in bacteriostasis, colitis alleviation and inflammatory bone loss improvement | 迪辅乐生物(上海)有限公司 | 2025-06-10 | — | — | CN | claimed |
| EP-4554629-A1 | METHODS AND FORMULATIONS FOR GENE THERAPY, AND FOR COMBINING GENE THERAPY WITH DITPA TREATMENT, OF ALLAN-HERNDON-DUDLEY SYNDROME | Prizm, LLC (US) | 2025-05-21 | — | — | EP | claimed |
| CN-119592463-A | HMO high-utilization strain dipro-15 | 迪辅乐生物(上海)有限公司 | 2025-03-11 | — | — | CN | claimed |
| CN-119570671-A | Application of bifidobacterium animalis in anti-inflammatory, anti-helicobacter pylori and improving obesity, hyperlipidemia and bone loss | 迪辅乐生物(上海)有限公司 | 2025-03-07 | — | — | CN | claimed |
| CN-119530336-A | Screening method of HMO high-utilization-rate strain and high-HMO utilization-rate strain | 迪辅乐生物(上海)有限公司 | 2025-02-28 | — | — | CN | claimed |
| US-20250066734-A1 | CULTURE MEDIUM COMPOSITION FOR MATURATING CARDIOMYOCYTES DERIVED FROM PLURIPOTENT MAMMALIAN STEM CELLS | NCARDIA B.V. (NL) | 2025-02-27 | — | — | US | claimed |
| CN-118685300-B | Bifidobacterium longum subspecies longum and application thereof in preventing, relieving, regulating or treating lipid metabolism related diseases | 迪辅乐生物(上海)有限公司 | 2025-02-18 | — | — | CN | claimed |
| CN-118497065-B | Bifidobacterium longum subspecies longum and application thereof in bacteriostasis or improvement of intestinal axis inflammation related diseases | 迪辅乐生物(上海)有限公司 | 2025-01-24 | — | — | CN | claimed |
| EP-1793814-A2 | THYROID HORMONE ANALOGS FOR PROMOTING ANGIOGENESIS | Ordway Research Institute (US) | 2007-06-13 | — | — | EP | claimed |
| JP-2007505837-A | — | — | 2007-03-15 | — | — | JP | claimed |
| EP-1670449-A2 | THYROID HORMONE ANALOGS AND METHODS OF USE IN ANGIOGENESIS | Ordway Research Institute (US) | 2006-06-21 | — | — | EP | claimed |
| EP-1432310-A4 | METHOD TO TREAT CHRONIC HEART FAILURE AND/OR ELEVATED CHOLESTEROL LEVELS USING 3,5-DIIODOTHYROPROPIONIC ACID AND METHOD TO PREPARE SAME | UNIV ARIZONA (US) | 2006-06-21 | — | — | EP | claimed |
| WO-2006031922-A2 | THYROID HORMONE ANALOGS FOR PROMOTING ANGIOGENESIS | ORDWAY RESEARCH INSTITUTE (US) | 2006-03-23 | — | — | WO | claimed |
| US-20050124862-A1 | Thyroid hormone analogs and methods of use | NANOPHARMACEUTICALS LLC | 2005-06-09 | — | — | US | claimed |
| WO-2005027895-A2 | THYROID HORMONE ANALOGS AND METHODS OF USE IN ANGIOGENESIS | ORDWAY RESEARCH INSTITUTE (US) | 2005-03-31 | — | — | WO | claimed |
| EP-1432310-A2 | METHOD TO TREAT CHRONIC HEART FAILURE AND/OR ELEVATED CHOLESTEROL LEVELS USING 3,5-DIIODOTHYROPROPIONIC ACID AND METHOD TO PREPARE SAME | The Arizona Board of Regents on Behalf of the University of Arizona (US) | 2004-06-30 | — | — | EP | claimed |
| US-6534676-B2 | Reacting ethyl-3-(3,5-diiodo-4-hydroxyphenyl)- propionate with dianisoleiodonium trifluoroacetate to form ethyl-3-(4'-methoxy-3,5-diiodothyro)-propionate; and reacting the intermediate with hydrogen iodide and glacial acetic acid | THE ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA | 2003-03-18 | — | — | US | claimed |
| WO-2002060389-A2 | METHOD TO TREAT CHRONIC HEART FAILURE AND/OR ELEVATED CHOLESTEROL LEVELS USING 3,5-DIIODOTHYROPROPIONIC ACID AND METHOD TO PREPARE SAME | THE ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2002-08-08 | — | — | WO | claimed |